1. Home
  2. STTK vs WASH Comparison

STTK vs WASH Comparison

Compare STTK & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$7.03

Market Cap

569.1M

Sector

Health Care

ML Signal

HOLD

Logo Washington Trust Bancorp Inc.

WASH

Washington Trust Bancorp Inc.

HOLD

Current Price

$32.09

Market Cap

682.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
WASH
Founded
2016
1800
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
569.1M
682.2M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
STTK
WASH
Price
$7.03
$32.09
Analyst Decision
Buy
Hold
Analyst Count
7
4
Target Price
$10.00
$30.25
AVG Volume (30 Days)
424.3K
204.5K
Earning Date
05-01-2026
04-20-2026
Dividend Yield
N/A
7.22%
EPS Growth
53.02
266.26
EPS
N/A
2.71
Revenue
$1,000,000.00
$229,048,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.19
P/E Ratio
N/A
$11.67
Revenue Growth
N/A
127.57
52 Week Low
$0.71
$25.23
52 Week High
$8.33
$37.08

Technical Indicators

Market Signals
Indicator
STTK
WASH
Relative Strength Index (RSI) 49.99 45.21
Support Level $5.75 $31.51
Resistance Level $7.68 $33.63
Average True Range (ATR) 0.52 1.15
MACD -0.13 -0.26
Stochastic Oscillator 17.27 31.78

Price Performance

Historical Comparison
STTK
WASH

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About WASH Washington Trust Bancorp Inc.

Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.

Share on Social Networks: